naltrexone and Chronic Hepatitis C

naltrexone has been researched along with Chronic Hepatitis C in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Memisoglu, A; Mitchell, MC; Silverman, BL	1
Douglas, SD; Ho, WZ; Lai, JP; Li, Y; Metzger, DS; O'Brien, CP; Zhang, T	1

Trials

1 trial(s) available for naltrexone and Chronic Hepatitis C

Article	Year
Hepatic safety of injectable extended-release naltrexone in patients with chronic hepatitis C and HIV infection. Journal of studies on alcohol and drugs, 2012, Volume: 73, Issue:6 Topics: Adult; Delayed-Action Preparations; Double-Blind Method; Female; Hepatitis C, Chronic; HIV Infections; Humans; Injections, Intramuscular; Liver Function Tests; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders	2012

Article

Year

Hepatic safety of injectable extended-release naltrexone in patients with chronic hepatitis C and HIV infection.

Journal of studies on alcohol and drugs, 2012, Volume: 73, Issue:6

Topics: Adult; Delayed-Action Preparations; Double-Blind Method; Female; Hepatitis C, Chronic; HIV Infections; Humans; Injections, Intramuscular; Liver Function Tests; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders

2012

Other Studies

1 other study(ies) available for naltrexone and Chronic Hepatitis C

Article	Year
Alcohol potentiates hepatitis C virus replicon expression. Hepatology (Baltimore, Md.), 2003, Volume: 38, Issue:1 Topics: Antidotes; Antiviral Agents; Cells, Cultured; Central Nervous System Depressants; Cyanamide; Drug Interactions; Ethanol; Fomepizole; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-gamma; Naltrexone; Narcotic Antagonists; NF-kappa B; Pyrazoles; Replicon; RNA, Viral	2003